Family-based samples can play an important role in genetic association studies

Ethan M. Lange, Jielin Sun, Leslie A. Lange, S. Lilly Zheng, David Duggan, John D. Carpten, Henrik Gronberg, William B Isaacs, Jianfeng Xu, Bao Li Chang

Research output: Contribution to journalArticle

Abstract

Over the past 2 decades, DNA samples from thousands of families have been collected and genotyped for linkage studies of common complex diseases, such as type 2 diabetes, asthma, and prostate cancer. Unfortunately, little success has been achieved in identifying genetic susceptibility risk factors through these considerable efforts. However, significant success in identifying common disease risk-associated variants has been recently achieved from genome-wide association studies using unrelated case-control samples. These genome-wide association studies are typically done using population-based cases and controls that are ascertained irrespective of their family history for the disease of interest. Few genetic association studies have taken full advantage of the considerable resources that are available from the linkage-based family collections despite evidence showing cases that have a positive family history of disease are more likely to carry common genetic variants associated with disease susceptibility. Herein, we argue that population stratification is still a concern in case-control genetic association studies, despite the development of analytic methods designed to account for this source of confounding, for a subset of single nucleotide polymorphisms in the genome, most notably those single nucleotide polymorphisms in regions involved with natural selection. We note that current analytic approaches designed to address the issue of population stratification in case-control studies cannot definitively distinguish between true and false associations, and we argue that family-based samples can still serve an invaluable role in following upfindings from case-control studies.

Original languageEnglish (US)
Pages (from-to)2208-2214
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume17
Issue number9
DOIs
StatePublished - Sep 2008

Fingerprint

Genetic Association Studies
Genome-Wide Association Study
Single Nucleotide Polymorphism
Case-Control Studies
Population
Genetic Selection
Disease Susceptibility
Genetic Predisposition to Disease
Type 2 Diabetes Mellitus
Prostatic Neoplasms
Asthma
Genome
DNA

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Lange, E. M., Sun, J., Lange, L. A., Zheng, S. L., Duggan, D., Carpten, J. D., ... Chang, B. L. (2008). Family-based samples can play an important role in genetic association studies. Cancer Epidemiology Biomarkers and Prevention, 17(9), 2208-2214. https://doi.org/10.1158/1055-9965.EPI-08-0183

Family-based samples can play an important role in genetic association studies. / Lange, Ethan M.; Sun, Jielin; Lange, Leslie A.; Zheng, S. Lilly; Duggan, David; Carpten, John D.; Gronberg, Henrik; Isaacs, William B; Xu, Jianfeng; Chang, Bao Li.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 17, No. 9, 09.2008, p. 2208-2214.

Research output: Contribution to journalArticle

Lange, EM, Sun, J, Lange, LA, Zheng, SL, Duggan, D, Carpten, JD, Gronberg, H, Isaacs, WB, Xu, J & Chang, BL 2008, 'Family-based samples can play an important role in genetic association studies', Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 9, pp. 2208-2214. https://doi.org/10.1158/1055-9965.EPI-08-0183
Lange, Ethan M. ; Sun, Jielin ; Lange, Leslie A. ; Zheng, S. Lilly ; Duggan, David ; Carpten, John D. ; Gronberg, Henrik ; Isaacs, William B ; Xu, Jianfeng ; Chang, Bao Li. / Family-based samples can play an important role in genetic association studies. In: Cancer Epidemiology Biomarkers and Prevention. 2008 ; Vol. 17, No. 9. pp. 2208-2214.
@article{d47736abbb3340ce87bf5800883aac09,
title = "Family-based samples can play an important role in genetic association studies",
abstract = "Over the past 2 decades, DNA samples from thousands of families have been collected and genotyped for linkage studies of common complex diseases, such as type 2 diabetes, asthma, and prostate cancer. Unfortunately, little success has been achieved in identifying genetic susceptibility risk factors through these considerable efforts. However, significant success in identifying common disease risk-associated variants has been recently achieved from genome-wide association studies using unrelated case-control samples. These genome-wide association studies are typically done using population-based cases and controls that are ascertained irrespective of their family history for the disease of interest. Few genetic association studies have taken full advantage of the considerable resources that are available from the linkage-based family collections despite evidence showing cases that have a positive family history of disease are more likely to carry common genetic variants associated with disease susceptibility. Herein, we argue that population stratification is still a concern in case-control genetic association studies, despite the development of analytic methods designed to account for this source of confounding, for a subset of single nucleotide polymorphisms in the genome, most notably those single nucleotide polymorphisms in regions involved with natural selection. We note that current analytic approaches designed to address the issue of population stratification in case-control studies cannot definitively distinguish between true and false associations, and we argue that family-based samples can still serve an invaluable role in following upfindings from case-control studies.",
author = "Lange, {Ethan M.} and Jielin Sun and Lange, {Leslie A.} and Zheng, {S. Lilly} and David Duggan and Carpten, {John D.} and Henrik Gronberg and Isaacs, {William B} and Jianfeng Xu and Chang, {Bao Li}",
year = "2008",
month = "9",
doi = "10.1158/1055-9965.EPI-08-0183",
language = "English (US)",
volume = "17",
pages = "2208--2214",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Family-based samples can play an important role in genetic association studies

AU - Lange, Ethan M.

AU - Sun, Jielin

AU - Lange, Leslie A.

AU - Zheng, S. Lilly

AU - Duggan, David

AU - Carpten, John D.

AU - Gronberg, Henrik

AU - Isaacs, William B

AU - Xu, Jianfeng

AU - Chang, Bao Li

PY - 2008/9

Y1 - 2008/9

N2 - Over the past 2 decades, DNA samples from thousands of families have been collected and genotyped for linkage studies of common complex diseases, such as type 2 diabetes, asthma, and prostate cancer. Unfortunately, little success has been achieved in identifying genetic susceptibility risk factors through these considerable efforts. However, significant success in identifying common disease risk-associated variants has been recently achieved from genome-wide association studies using unrelated case-control samples. These genome-wide association studies are typically done using population-based cases and controls that are ascertained irrespective of their family history for the disease of interest. Few genetic association studies have taken full advantage of the considerable resources that are available from the linkage-based family collections despite evidence showing cases that have a positive family history of disease are more likely to carry common genetic variants associated with disease susceptibility. Herein, we argue that population stratification is still a concern in case-control genetic association studies, despite the development of analytic methods designed to account for this source of confounding, for a subset of single nucleotide polymorphisms in the genome, most notably those single nucleotide polymorphisms in regions involved with natural selection. We note that current analytic approaches designed to address the issue of population stratification in case-control studies cannot definitively distinguish between true and false associations, and we argue that family-based samples can still serve an invaluable role in following upfindings from case-control studies.

AB - Over the past 2 decades, DNA samples from thousands of families have been collected and genotyped for linkage studies of common complex diseases, such as type 2 diabetes, asthma, and prostate cancer. Unfortunately, little success has been achieved in identifying genetic susceptibility risk factors through these considerable efforts. However, significant success in identifying common disease risk-associated variants has been recently achieved from genome-wide association studies using unrelated case-control samples. These genome-wide association studies are typically done using population-based cases and controls that are ascertained irrespective of their family history for the disease of interest. Few genetic association studies have taken full advantage of the considerable resources that are available from the linkage-based family collections despite evidence showing cases that have a positive family history of disease are more likely to carry common genetic variants associated with disease susceptibility. Herein, we argue that population stratification is still a concern in case-control genetic association studies, despite the development of analytic methods designed to account for this source of confounding, for a subset of single nucleotide polymorphisms in the genome, most notably those single nucleotide polymorphisms in regions involved with natural selection. We note that current analytic approaches designed to address the issue of population stratification in case-control studies cannot definitively distinguish between true and false associations, and we argue that family-based samples can still serve an invaluable role in following upfindings from case-control studies.

UR - http://www.scopus.com/inward/record.url?scp=53349108674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53349108674&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-08-0183

DO - 10.1158/1055-9965.EPI-08-0183

M3 - Article

VL - 17

SP - 2208

EP - 2214

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -